Research ArticleArticle
International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List
Steven M. Foord, Tom I. Bonner, Richard R. Neubig, Edward M. Rosser, Jean-Phillipe Pin, Anthony P. Davenport, Michael Spedding and Anthony J. Harmar
Pharmacological Reviews June 2005, 57 (2) 279-288; DOI: https://doi.org/10.1124/pr.57.2.5
Steven M. Foord
GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, United Kingdom (S.M.F.); Laboratory of Genetics, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.); Division of Neuroscience and Centre for Neuroscience Research, University of Edinburgh, Edinburgh, United Kingdom (E.M.R., A.J.H.); Centre National de la Recherche Scientifique, Montpellier, France (J.-P.P.); Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (A.P.D); and Institut de Recherches Servier (I.d.R.S.), Suresnes, France (M.S.)
Tom I. Bonner
GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, United Kingdom (S.M.F.); Laboratory of Genetics, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.); Division of Neuroscience and Centre for Neuroscience Research, University of Edinburgh, Edinburgh, United Kingdom (E.M.R., A.J.H.); Centre National de la Recherche Scientifique, Montpellier, France (J.-P.P.); Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (A.P.D); and Institut de Recherches Servier (I.d.R.S.), Suresnes, France (M.S.)
Richard R. Neubig
GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, United Kingdom (S.M.F.); Laboratory of Genetics, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.); Division of Neuroscience and Centre for Neuroscience Research, University of Edinburgh, Edinburgh, United Kingdom (E.M.R., A.J.H.); Centre National de la Recherche Scientifique, Montpellier, France (J.-P.P.); Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (A.P.D); and Institut de Recherches Servier (I.d.R.S.), Suresnes, France (M.S.)
Edward M. Rosser
GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, United Kingdom (S.M.F.); Laboratory of Genetics, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.); Division of Neuroscience and Centre for Neuroscience Research, University of Edinburgh, Edinburgh, United Kingdom (E.M.R., A.J.H.); Centre National de la Recherche Scientifique, Montpellier, France (J.-P.P.); Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (A.P.D); and Institut de Recherches Servier (I.d.R.S.), Suresnes, France (M.S.)
Jean-Phillipe Pin
GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, United Kingdom (S.M.F.); Laboratory of Genetics, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.); Division of Neuroscience and Centre for Neuroscience Research, University of Edinburgh, Edinburgh, United Kingdom (E.M.R., A.J.H.); Centre National de la Recherche Scientifique, Montpellier, France (J.-P.P.); Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (A.P.D); and Institut de Recherches Servier (I.d.R.S.), Suresnes, France (M.S.)
Anthony P. Davenport
GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, United Kingdom (S.M.F.); Laboratory of Genetics, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.); Division of Neuroscience and Centre for Neuroscience Research, University of Edinburgh, Edinburgh, United Kingdom (E.M.R., A.J.H.); Centre National de la Recherche Scientifique, Montpellier, France (J.-P.P.); Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (A.P.D); and Institut de Recherches Servier (I.d.R.S.), Suresnes, France (M.S.)
Michael Spedding
GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, United Kingdom (S.M.F.); Laboratory of Genetics, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.); Division of Neuroscience and Centre for Neuroscience Research, University of Edinburgh, Edinburgh, United Kingdom (E.M.R., A.J.H.); Centre National de la Recherche Scientifique, Montpellier, France (J.-P.P.); Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (A.P.D); and Institut de Recherches Servier (I.d.R.S.), Suresnes, France (M.S.)
Anthony J. Harmar
GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, United Kingdom (S.M.F.); Laboratory of Genetics, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.); Division of Neuroscience and Centre for Neuroscience Research, University of Edinburgh, Edinburgh, United Kingdom (E.M.R., A.J.H.); Centre National de la Recherche Scientifique, Montpellier, France (J.-P.P.); Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (A.P.D); and Institut de Recherches Servier (I.d.R.S.), Suresnes, France (M.S.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List
Steven M. Foord, Tom I. Bonner, Richard R. Neubig, Edward M. Rosser, Jean-Phillipe Pin, Anthony P. Davenport, Michael Spedding and Anthony J. Harmar
Pharmacological Reviews June 1, 2005, 57 (2) 279-288; DOI: https://doi.org/10.1124/pr.57.2.5
Research ArticleArticle
International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List
Steven M. Foord, Tom I. Bonner, Richard R. Neubig, Edward M. Rosser, Jean-Phillipe Pin, Anthony P. Davenport, Michael Spedding and Anthony J. Harmar
Pharmacological Reviews June 1, 2005, 57 (2) 279-288; DOI: https://doi.org/10.1124/pr.57.2.5
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement